Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Cross

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
EMI. Animal & Environment|July 31, 2025
Pathogenesis of Chapare virus in cynomolgus macaquesDylan M Johnson, Courtney Woolsey, Krystle N Agans, et al.
The Journal of Infectious Diseases|October 31, 2019
An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green MonkeysJoan B Geisbert, Viktoriya Borisevich, Abhishek N Prasad, et al.
Scientific Reports|November 15, 2019
Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret modelBenjamin A Satterfield, Viktoriya Borisevich, Stephanie L Foster, et al.
NPJ Vaccines|January 3, 2026
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challengeDeclan D Pigeaud, Viktoriya Borisevich, Krystle N Agans, et al.
Nature|January 7, 2026
Oral 4'-fluorouridine rescues nonhuman primates from advanced Lassa feverRobert W Cross, Jacquelyn Turcinovic, Abhishek N Prasad, et al.
The Journal of Infectious Diseases|November 6, 2019
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus InfectionChad E Mire, Yee-Peng Chan, Viktoriya Borisevich, et al.
The Journal of Clinical Investigation|March 31, 2026
Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challengeNathaniel S Chapman, Viktoriya Borisevich, Nurgun Kose, et al.
The Journal of Infectious Diseases|June 26, 2018
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman PrimatesCourtney Woolsey, Joan B Geisbert, Demetrius Matassov, et al.
Nature Communications|April 23, 2025
Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virusAbhishek N Prasad, Courtney Woolsey, Viktoriya Borisevich, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2022
A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus diseaseStephanie L Foster, Courtney Woolsey, Viktoriya Borisevich, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
EMI. Animal & Environment|July 31, 2025
Pathogenesis of Chapare virus in cynomolgus macaquesDylan M Johnson, Courtney Woolsey, Krystle N Agans, et al.
The Journal of Infectious Diseases|October 31, 2019
An Intranasal Exposure Model of Lethal Nipah Virus Infection in African Green MonkeysJoan B Geisbert, Viktoriya Borisevich, Abhishek N Prasad, et al.
Scientific Reports|November 15, 2019
Antagonism of STAT1 by Nipah virus P gene products modulates disease course but not lethal outcome in the ferret modelBenjamin A Satterfield, Viktoriya Borisevich, Stephanie L Foster, et al.
NPJ Vaccines|January 3, 2026
A single-cycle recombinant VSV vaccine displaying the Hendra virus glycoprotein uniformly protects against Hendra and Nipah virus challengeDeclan D Pigeaud, Viktoriya Borisevich, Krystle N Agans, et al.
Nature|January 7, 2026
Oral 4'-fluorouridine rescues nonhuman primates from advanced Lassa feverRobert W Cross, Jacquelyn Turcinovic, Abhishek N Prasad, et al.
The Journal of Infectious Diseases|November 6, 2019
A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus InfectionChad E Mire, Yee-Peng Chan, Viktoriya Borisevich, et al.
The Journal of Clinical Investigation|March 31, 2026
Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challengeNathaniel S Chapman, Viktoriya Borisevich, Nurgun Kose, et al.
The Journal of Infectious Diseases|June 26, 2018
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman PrimatesCourtney Woolsey, Joan B Geisbert, Demetrius Matassov, et al.
Nature Communications|April 23, 2025
Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virusAbhishek N Prasad, Courtney Woolsey, Viktoriya Borisevich, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2022
A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus diseaseStephanie L Foster, Courtney Woolsey, Viktoriya Borisevich, et al.
Pageof 13